LMAT (LeMaitre Vascular) Owner Earnings per Share (TTM): 2.58 (As of Jun. 2026) — 94% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LMAT LeMaitre Vascular Inc LMAT
100 GF Score
Price $81.45
GF Value $95.26
Valuation Modestly Undervalued
View Full Analysis

What is LeMaitre Vascular Owner Earnings per Share (TTM)?

LeMaitre Vascular LMAT +0.78% 100 Owner Earnings per Share (TTM) is 2.58 as of Jun. 2026, which is 94% below its 10-year median of 44.62. GuruFocus rates LMAT with a GF Score™ of 100/100 and a GF Value™ of $95.26 (Modestly Undervalued). Among 315 Medical Devices & Instruments companies, LeMaitre Vascular ranks worse than 55.56% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

LeMaitre Vascular's Owner Earnings per Share (TTM) ended in Jun. 2026 was $2.58. It's Price-to-Owner-Earnings ratio for today is 31.57.


The historical rank and industry rank for LeMaitre Vascular's Owner Earnings per Share (TTM) or its related term are showing as below:

LMAT' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 20.09   Med: 44.62   Max: 143.6
Current: 31.58


During the past 13 years, the highest Price-to-Owner-Earnings ratio of LeMaitre Vascular was 143.60. The lowest was 20.09. And the median was 44.62.


LMAT's Price-to-Owner-Earnings is ranked worse than
55.56% of 315 companies
in the Medical Devices & Instruments industry
Industry Median: 27.42 vs LMAT: 31.58

LeMaitre Vascular's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was $0.74. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was $2.85. It's PE Ratio (TTM) ratio for today is 28.58.

LeMaitre Vascular's EPS without NRI for the three months ended in Jun. 2026 was $0.74. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was $2.61. It's PE Ratio without NRI ratio for today is 31.27.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


LeMaitre Vascular Owner Earnings per Share (TTM) Related Terms


LeMaitre Vascular Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for LeMaitre Vascular's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LeMaitre Vascular Owner Earnings per Share (TTM) Chart

LeMaitre Vascular Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.10 0.62 1.11 1.30 2.71

LeMaitre Vascular Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.94 2.36 2.71 2.95 0.00

LMAT vs PLSE, XRAY, ATRC: Owner Earnings per Share (TTM) Comparison

For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LeMaitre Vascular Price-to-Owner-Earnings vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where LeMaitre Vascular's Price-to-Owner-Earnings falls into.


LMAT
100GF Score
LeMaitre Vascular Inc LMAT
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LeMaitre Vascular Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

LeMaitre Vascular's Owner Earnings per Share (TTM) Calculation:

TTM / Last Quarter Average of Last 20 Quarters
Net Income 65.7
Depreciation, Depletion and Amortization 10.5
Change In Deferred Tax 0.0
5Y Average of Maintenance Capital Expenditure 4.7
Change In Working Capital -8.2
Shares Outstanding (Diluted Average) 24.5

1. Start with "Net Income" from income statement. LeMaitre Vascular's Net Income for the trailing twelve months (TTM) ended in Jun. 2026 was $65.7 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. LeMaitre Vascular's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Jun. 2026 was $10.5 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. LeMaitre Vascular's Change In Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2026 was $0.0 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = $4.7 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous quarter. If the revenue decreased from the previous quarter, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous quarter, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

LeMaitre Vascular's 5-Year Average Maintenance Capital Expenditure = $4.7 Mil

5. "Change In Working Capital" is from cashflow statement. LeMaitre Vascular's Change In Working Capital for the trailing twelve months (TTM) ended in Jun. 2026 was $-8.2 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. LeMaitre Vascular's Shares Outstanding (Diluted Average) for the months ended in Jun. 2026 was 24.531 Mil.

LeMaitre Vascular's Onwer Earnings Per Share for Jun. 2026 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 65.673 +10.503+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-4.7209915636652+-8.228)/24.531
=2.58

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=81.45/2.58
=31.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of 2.58 mean?
LeMaitre Vascular (LMAT) has a Owner Earnings per Share (TTM) of 2.58 as of Jun. 2026. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on LeMaitre Vascular. This is 94% below median its historical median of 44.62. Over the past decade, LeMaitre Vascular's Owner Earnings per Share (TTM) has ranged from 20.09 to 143.60. According to the industry distribution chart, LeMaitre Vascular ranks #175 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 55.6%.
Is LeMaitre Vascular's Owner Earnings per Share (TTM) too high?
LeMaitre Vascular's current Owner Earnings per Share (TTM) of 2.58 is 94% below median its 10-year median of 44.62. Over the past 10 years, this metric has ranged from a low of 20.09 to a high of 143.60. The Medical Devices & Instruments industry median Owner Earnings per Share (TTM) is 27.42. LeMaitre Vascular's value of 2.58 is 90.6% below this industry median. Based on the distribution chart, LeMaitre Vascular ranks #175 out of 315 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, LeMaitre Vascular has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LeMaitre Vascular's Owner Earnings per Share (TTM) compare to PLSE and XRAY?
According to the Medical Devices & Instruments industry distribution chart, LeMaitre Vascular ranks #175 out of 315 companies for Owner Earnings per Share (TTM). This places LeMaitre Vascular in the lower half of its industry. The industry median Owner Earnings per Share (TTM) is 27.42. LeMaitre Vascular's value of 2.58 is 90.6% below this benchmark. Historically, LeMaitre Vascular's own Owner Earnings per Share (TTM) has ranged from 20.09 to 143.60 over the past decade. While the company's 10-year median is 44.62 vs. the industry median of 27.42, LeMaitre Vascular has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Medical Devices & Instruments company?
The median Owner Earnings per Share (TTM) among Medical Devices & Instruments companies is 27.42, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LeMaitre Vascular's current Owner Earnings per Share (TTM) of 2.58 is 90.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on LeMaitre Vascular. For the Medical Devices & Instruments industry, the median Owner Earnings per Share (TTM) is 27.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LeMaitre Vascular's current Owner Earnings per Share (TTM) is 2.58, which is 94% below median its own 10-year median of 44.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeMaitre Vascular stock overvalued right now?
Based on GuruFocus' analysis, LeMaitre Vascular (LMAT) is currently considered Modestly Undervalued. The stock's GF Value™ is $95.26, compared to a current price of $81.45 — trading 14.5% below its estimated fair value. The current Owner Earnings per Share (TTM) is 2.58, which is 94% below median its 10-year median of 44.62 and 90.6% below the Medical Devices & Instruments industry median of 27.42. LeMaitre Vascular's overall GF Score™ is 100/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For LeMaitre Vascular (LMAT), the current Owner Earnings per Share (TTM) is 2.58 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LeMaitre Vascular (LMAT) Overvalued in 2026?

Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued. The current stock price of $81.45 is trading 14.5% below its estimated GF Value™ of $95.26. GuruFocus considers LeMaitre Vascular to be Modestly Undervalued.

Key valuation signals for LMAT:

  • Owner Earnings per Share (TTM): 2.58 (94% below median its 10-year median of 44.62)
  • GF Value™: $95.26 vs. price of $81.45 (14.5% below fair value)
  • GF Score™: 100/100
  • Industry Position: 90.6% below the Medical Devices & Instruments median (#175 of 315)

No single metric tells the full story. See the LMAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LeMaitre Vascular Business Description

Other Exchanges LHU:Germany
Address 63 Second Avenue, Burlington, MA, USA, 01803
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
100GF Score

Get the complete analysis for LMAT

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$81.45
Price
$95.26
GF Value